A breakthrough has been made with vaccines, with a second vaccine being 94.5% effective.
British scientists have hailed the “hugely exciting” news that a US coronavirus vaccine could prevent 94.5% of people from getting Covid-19.
The results come less than a week after similar results from Pfizer and add to growing confidence that vaccines can help end the pandemic.
Interim results from the US company Moderna suggest that its vaccine is highly effective against disease and also works in all age groups, including the elderly.
The UK has not placed an order for the vaccine – which works similarly to Pfizer’s – and it is unclear whether the UK government can get supplies.
However, scientists said the news bodes well for other Covid-19 vaccines, with the one for Oxford University and UK pharmaceutical giant AstraZeneca slated to be released in the coming days or weeks.
Cases in your area:
Moderna intends to file an application for emergency approval with the US Food and Drug Administration shortly and provide additional data on the efficacy and safety of the vaccine.
Downing Street confirmed talks had been held with Moderna about access to its vaccine, but stressed that orders had already been placed in the UK for other possible treatments.
The Prime Minister’s official spokesman said: “The news from Moderna is another important step on the road to an effective Covid-19 vaccine.
“Advanced discussions are ongoing to secure cans for the UK.
“We have already had early access to 350 million doses of vaccine through agreements for six different vaccines, giving the UK the most likely chance of getting a safe and effective vaccine at the fastest rate.”
“We have prioritized agreements with vaccine developers who offer different types of vaccines, allow early delivery to the UK and have advanced supply chains for manufacturing.”